Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-Lift Trial)

Diabetes Care - United States
doi 10.2337/dc18-0165

Related search